5 years since the pandemic started, long COVID patients are still hoping for a cure
They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a way to go.
4 weeks ago
Ray Hoffman, (right) who is immunocompromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro (center), a medical assistant at a University of Washington Medicine clinic in Seattle as Cynde Wiederhold, a nurse, looks on. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)